We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+7.84%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.42B
AUM Growth
+$116M
Cap. Flow
+$31.3M
Cap. Flow %
2.2%
Top 10 Hldgs %
38.27%
Holding
219
New
27
Increased
45
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.69M
2
PYPL icon
PayPal
PYPL
+$5.46M
3
FMC icon
FMC
FMC
+$4.66M
4
PPLI
People Inc
PPLI
+$4.25M
5
AR icon
Antero Resources
AR
+$3.32M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$14.3M
2
AAPL icon
Apple
AAPL
+$5.37M
3
LBRDK icon
Liberty Broadband Class C
LBRDK
+$4.47M
4
CHTR icon
Charter Communications
CHTR
+$2.11M
5
PXD
Pioneer Natural Resource Co.
PXD
+$1.87M

Sector Composition

Rank Sector Weight
1 Healthcare 17.38%
2 Technology 17.25%
3 Materials 12.26%
4 Communication Services 9.41%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDLZ icon
151
Mondelez International
MDLZ
$77.9B
$742K 0.05%
10,608
+7,015
+195% +$512K
IAU icon
152
iShares Gold Trust
IAU
$63.4B
$721K 0.05%
17,174
– –
KO icon
153
Coca-Cola
KO
$361B
$717K 0.05%
11,725
– –
IWR icon
154
iShares Russell Mid-Cap ETF
IWR
$56.1B
$701K 0.05%
8,344
– –
NBIX icon
155
Neurocrine Biosciences
NBIX
$17.8B
$689K 0.05%
+5,000
New +$683K
MTD icon
156
Mettler-Toledo International
MTD
$26.9B
$665K 0.05%
500
+140
+39% +$173K
EVH icon
157
Evolent Health
EVH
$433M
$655K 0.05%
+20,000
New +$638K
NXDR
158
Nextdoor Holdings
NXDR
$866M
$645K 0.05%
287,000
– –
BPMC
159
DELISTED
Blueprint Medicines
BPMC
$635K 0.04%
+6,700
New +$575K
CW icon
160
Curtiss-Wright
CW
$27.2B
$607K 0.04%
2,372
– –
ETR icon
161
Entergy
ETR
$53.2B
$600K 0.04%
11,366
– –
SXI icon
162
Standex International
SXI
$3.73B
$592K 0.04%
3,250
– –
TT icon
163
Trane Technologies
TT
$106B
$588K 0.04%
1,960
– –
UPS icon
164
United Parcel Service
UPS
$95.9B
$560K 0.04%
3,770
– –
CTAS icon
165
Cintas
CTAS
$84.2B
$549K 0.04%
3,200
-400
-11% -$61.6K
IWF icon
166
iShares Russell 1000 Growth ETF
IWF
$120B
$548K 0.04%
6,508
+632
+11% +$50.9K
GEHC icon
167
GE HealthCare
GEHC
$27.9B
$540K 0.04%
5,947
-7,281
-55% -$606K
PNC icon
168
PNC Financial Services
PNC
$99.5B
$452K 0.03%
2,800
– –
WMT icon
169
Walmart Inc
WMT
$889B
$451K 0.03%
7,500
– –
MRSH
170
Marsh
MRSH
$87.5B
$411K 0.03%
2,000
– –
BA icon
171
Boeing
BA
$168B
$389K 0.03%
2,020
-3,000
-60% -$616K
LKQ icon
172
LKQ Corp
LKQ
$6.68B
$384K 0.03%
7,200
– –
TXN icon
173
Texas Instruments
TXN
$256B
$360K 0.03%
2,070
– –
IWO icon
174
iShares Russell 2000 Growth ETF
IWO
$14.5B
$359K 0.03%
1,329
– –
DE icon
175
Deere & Co
DE
$168B
$353K 0.02%
860
– –
5 6
7
8 9

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

S&CO Inc's Q1 2024 Portfolio in Review

As of Q1 2024, S&CO Inc held 219 positions worth $1.42B, up 8.9% from $1.3B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

S&CO Inc's Q1 2024 filing shows 27 new, 45 increased, 60 reduced and 9 closed positions. Its largest new stake was Illumina: 24,209 shares worth $3.23M. The largest sale was Bristol-Myers Squibb, an estimated $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Materials.

  • S&CO Inc's largest Q1 2024 buy was Illumina: 24,209 shares worth $3.23M.
  • S&CO Inc added most to UnitedHealth in Q1 2024, an estimated $9.69M increase.
  • S&CO Inc's biggest Q1 2024 reduction was Apple, cutting an estimated $5.37M.
  • S&CO Inc fully exited Bristol-Myers Squibb in Q1 2024, selling an estimated $14.3M.
  • S&CO Inc's ten largest holdings make up 38% of its $1.42B portfolio in Q1 2024.
  • S&CO Inc opened 27 new positions and closed 9 in Q1 2024.
  • S&CO Inc's portfolio value rose 8.9% quarter-over-quarter to $1.42B.

Based on S&CO Inc's 13F filing for Q1 2024, filed 9 May 2024.